Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.

Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S, Wang B, Suster S, Jacob ST, Ghoshal K.

J Biol Chem. 2018 Aug 17;293(33):12945. doi: 10.1074/jbc.W118.004967. No abstract available.

2.

The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer.

Barajas JM, Reyes R, Guerrero MJ, Jacob ST, Motiwala T, Ghoshal K.

Sci Rep. 2018 Jun 14;8(1):9105. doi: 10.1038/s41598-018-27358-5.

3.

CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128.

Badawi M, Kim J, Dauki A, Sutaria D, Motiwala T, Reyes R, Wani N, Kolli S, Jiang J, Coss CC, Jacob ST, Phelps MA, Schmittgen TD.

Oncotarget. 2018 May 25;9(40):26032-26045. doi: 10.18632/oncotarget.25430. eCollection 2018 May 25.

4.

Correction for Ghoshal et al., "5-Aza-Deoxycytidine Induces Selective Degradation of DNA Methyltransferase 1 by a Proteasomal Pathway That Requires the KEN Box, Bromo-Adjacent Homology Domain, and Nuclear Localization Signal".

Ghoshal K, Datta J, Majumder S, Bai S, Kutay H, Motiwala T, Jacob ST.

Mol Cell Biol. 2018 Apr 30;38(10). pii: e00539-17. doi: 10.1128/MCB.00539-17. Print 2018 May 15. No abstract available.

5.

PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells.

Motiwala T, Majumder S, Ghoshal K, Kutay H, Datta J, Roy S, Lucas DM, Jacob ST.

J Biol Chem. 2018 Mar 9;293(10):3589. doi: 10.1074/jbc.W118.002431. No abstract available.

6.

Reprograming of Glucose Metabolism by Zerumbone Suppresses Hepatocarcinogenesis.

Wani NA, Zhang B, Teng KY, Barajas JM, Motiwala T, Hu P, Yu L, Br├╝schweiler R, Ghoshal K, Jacob ST.

Mol Cancer Res. 2018 Feb;16(2):256-268. doi: 10.1158/1541-7786.MCR-17-0304. Epub 2017 Nov 29.

7.

Triggered intracellular calcium waves in dog and human left atrial myocytes from normal and failing hearts.

Aistrup GL, Arora R, Grubb S, Yoo S, Toren B, Kumar M, Kunamalla A, Marszalec W, Motiwala T, Tai S, Yamakawa S, Yerrabolu S, Alvarado FJ, Valdivia HH, Cordeiro JM, Shiferaw Y, Wasserstrom JA.

Cardiovasc Res. 2017 Nov 1;113(13):1688-1699. doi: 10.1093/cvr/cvx167.

8.

Sorafenib and 2-Deoxyglucose Synergistically Inhibit Proliferation of Both Sorafenib-Sensitive and -Resistant HCC Cells by Inhibiting ATP Production.

Reyes R, Wani NA, Ghoshal K, Jacob ST, Motiwala T.

Gene Expr. 2017 Feb 10;17(2):129-140. doi: 10.3727/105221616X693855. Epub 2016 Nov 16.

9.

Domain Analysis of Integrated Data to Reduce Cost Associated with Liver Disease.

Motiwala T, Kite B, Regan K, Gascon GM, Payne PR.

Stud Health Technol Inform. 2015;216:414-8.

10.

Mutations in DCHS1 cause mitral valve prolapse.

Durst R, Sauls K, Peal DS, deVlaming A, Toomer K, Leyne M, Salani M, Talkowski ME, Brand H, Perrocheau M, Simpson C, Jett C, Stone MR, Charles F, Chiang C, Lynch SN, Bouatia-Naji N, Delling FN, Freed LA, Tribouilloy C, Le Tourneau T, LeMarec H, Fernandez-Friera L, Solis J, Trujillano D, Ossowski S, Estivill X, Dina C, Bruneval P, Chester A, Schott JJ, Irvine KD, Mao Y, Wessels A, Motiwala T, Puceat M, Tsukasaki Y, Menick DR, Kasiganesan H, Nie X, Broome AM, Williams K, Johnson A, Markwald RR, Jeunemaitre X, Hagege A, Levine RA, Milan DJ, Norris RA, Slaugenhaupt SA.

Nature. 2015 Sep 3;525(7567):109-13. doi: 10.1038/nature14670. Epub 2015 Aug 10.

11.

Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation.

Alinari L, Mahasenan KV, Yan F, Karkhanis V, Chung JH, Smith EM, Quinion C, Smith PL, Kim L, Patton JT, Lapalombella R, Yu B, Wu Y, Roy S, De Leo A, Pileri S, Agostinelli C, Ayers L, Bradner JE, Chen-Kiang S, Elemento O, Motiwala T, Majumder S, Byrd JC, Jacob S, Sif S, Li C, Baiocchi RA.

Blood. 2015 Apr 16;125(16):2530-43. doi: 10.1182/blood-2014-12-619783. Epub 2015 Mar 5.

12.

PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model.

Motiwala T, Kutay H, Zanesi N, Frissora FW, Mo X, Muthusamy N, Jacob ST.

Leukemia. 2015 Jun;29(6):1350-9. doi: 10.1038/leu.2014.341. Epub 2014 Dec 8.

13.
14.

Use of platelet-rich fibrin as an autologous biologic rejuvenating media for avulsed teeth - an in vitro study.

Hiremath H, Kulkarni S, Sharma R, Hiremath V, Motiwala T.

Dent Traumatol. 2014 Dec;30(6):442-6. doi: 10.1111/edt.12119. Epub 2014 Jun 13.

PMID:
24924343
15.

Regulation of glucose metabolism in hepatocarcinogenesis by microRNAs.

Reyes RK, Motiwala T, Jacob ST.

Gene Expr. 2014;16(2):85-92. doi: 10.3727/105221614X13919976902093. Review.

16.

Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate.

Hsu SH, Motiwala T, Roy S, Claus R, Mustafa M, Plass C, Freitas MA, Ghoshal K, Jacob ST.

J Cell Biochem. 2013 Aug;114(8):1810-8. doi: 10.1002/jcb.24525.

17.

Reduced susceptibility of DNA methyltransferase 1 hypomorphic (Dnmt1N/+) mice to hepatic steatosis upon feeding liquid alcohol diet.

Kutay H, Klepper C, Wang B, Hsu SH, Datta J, Yu L, Zhang X, Majumder S, Motiwala T, Khan N, Belury M, McClain C, Jacob S, Ghoshal K.

PLoS One. 2012;7(8):e41949. doi: 10.1371/journal.pone.0041949. Epub 2012 Aug 8.

18.
19.

AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia.

Motiwala T, Zanesi N, Datta J, Roy S, Kutay H, Checovich AM, Kaou M, Zhong Y, Johnson AJ, Lucas DM, Heerema NA, Hagan J, Mo X, Jarjoura D, Byrd JC, Croce CM, Jacob ST.

Blood. 2011 Dec 1;118(23):6132-40. doi: 10.1182/blood-2011-01-323147. Epub 2011 Oct 14.

20.

Lyn kinase and ZAP70 are substrates of PTPROt in B-cells: Lyn inactivation by PTPROt sensitizes leukemia cells to VEGF-R inhibitor pazopanib.

Motiwala T, Datta J, Kutay H, Roy S, Jacob ST.

J Cell Biochem. 2010 Jul 1;110(4):846-56. doi: 10.1002/jcb.22593.

21.

HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors.

Ghoshal K, Motiwala T, Claus R, Yan P, Kutay H, Datta J, Majumder S, Bai S, Majumder A, Huang T, Plass C, Jacob ST.

PLoS One. 2010 Apr 29;5(4):e10338. doi: 10.1371/journal.pone.0010338.

22.

Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity.

Ramaswamy B, Majumder S, Roy S, Ghoshal K, Kutay H, Datta J, Younes M, Shapiro CL, Motiwala T, Jacob ST.

Mol Endocrinol. 2009 Feb;23(2):176-87. doi: 10.1210/me.2008-0211. Epub 2008 Dec 18.

23.

PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells.

Motiwala T, Majumder S, Ghoshal K, Kutay H, Datta J, Roy S, Lucas DM, Jacob ST.

J Biol Chem. 2009 Jan 2;284(1):455-64. doi: 10.1074/jbc.M802840200. Epub 2008 Nov 7. Retraction in: J Biol Chem. 2018 Mar 9;293(10 ):3589.

24.

Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.

Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S, Wang B, Suster S, Jacob ST, Ghoshal K.

J Biol Chem. 2008 Nov 28;283(48):33394-405. doi: 10.1074/jbc.M804788200. Epub 2008 Sep 25. Retraction in: J Biol Chem. 2018 Aug 17;293(33):12945.

25.

Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia.

Motiwala T, Majumder S, Kutay H, Smith DS, Neuberg DS, Lucas DM, Byrd JC, Grever M, Jacob ST.

Clin Cancer Res. 2007 Jun 1;13(11):3174-81.

26.
27.

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas.

Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, Jacob ST, Ghoshal K.

J Cell Biochem. 2006 Oct 15;99(3):671-8.

28.

Role of protein tyrosine phosphatases in cancer.

Motiwala T, Jacob ST.

Prog Nucleic Acid Res Mol Biol. 2006;81:297-329. Review. No abstract available.

30.
31.

Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer.

Motiwala T, Kutay H, Ghoshal K, Bai S, Seimiya H, Tsuruo T, Suster S, Morrison C, Jacob ST.

Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13844-9. Epub 2004 Sep 8.

32.

Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression.

Ghoshal K, Majumder S, Datta J, Motiwala T, Bai S, Sharma SM, Frankel W, Jacob ST.

J Biol Chem. 2004 Feb 20;279(8):6783-93. Epub 2003 Nov 10.

33.

Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas.

Motiwala T, Ghoshal K, Das A, Majumder S, Weichenhan D, Wu YZ, Holman K, James SJ, Jacob ST, Plass C.

Oncogene. 2003 Sep 25;22(41):6319-31.

Supplemental Content

Loading ...
Support Center